Mendus AB: Mendus to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting 2023
DURABLE VACCINE–INDUCED T-CELL RESPONSES OBSERVED IN THE MAJORITY OF VIDIDENCEL-TREATED PATIENTS Mendus AB (“Mendus” publ;…
DURABLE VACCINE–INDUCED T-CELL RESPONSES OBSERVED IN THE MAJORITY OF VIDIDENCEL-TREATED PATIENTS Mendus AB (“Mendus” publ;…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland…
MONT-SAINT-GUIBERT, Belgium, March 15, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the…
Motul set to be official supplier for all race teams at the resurgent endurance classic…
HONG KONG, Mar 15, 2023 – (ACN Newswire) – Impro Precision (01286.HK), one of the…
$250,000 top award goes to Neel Moudgal in the nation’s oldest and most prestigious science…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
NUREMBERG, Germany–(BUSINESS WIRE)–Thundercomm, a world leading IoT product and solution provider, today announces its expanded…
“Las Culturistas” takes home coveted Podcast of the Year Award presented by Autonomy Emmy award-winning…
BOSTON, March 14, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced the…
Tokyo, Japan and Cambridge, UK, 15 March 2023 – Sosei Group Corporation (“the Company”; TSE:…
Data show that sudocetaxel zendusortide (TH1902) can induce tumor infiltrating lymphocytes and potentiate anti-PD-L1 immunotherapy…
Preclinical abstracts for investigational T cell engagers, HPN328 and HPN217, in mouse models provide further…
Company has initiated enrollment of patients into the monotherapy expansion cohorts Company to host a…
ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical…
– Clinical posters detail results of dose escalation portion of phase 1b/2 trials of ADG126…
Mablink Bioscience to Present Promising Preclinical Data for Lead ADC Candidate MBK-103 at the AACR…
BOSTON and SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Frontier Medicines Corporation,…
– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine…
Initial Data Provide Proof-of-Concept for an anti-CD70 AlloCAR T Candidate in Patients with Renal Cell…